Christopher Ogden - Net Worth and Insider Trading

Christopher Ogden Net Worth

The estimated net worth of Christopher Ogden is at least $136,241 dollars as of 2024-04-29. Christopher Ogden is the SVP, Finance and Accounting of CytomX Therapeutics Inc and owns about 85,686 shares of CytomX Therapeutics Inc (CTMX) stock worth over $136,241. Details can be seen in Christopher Ogden's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Christopher Ogden has not made any transactions after 2024-03-19 and currently still holds the listed stock(s).

Transaction Summary of Christopher Ogden

To

Christopher Ogden Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Christopher Ogden owns 1 companies in total, including CytomX Therapeutics Inc (CTMX) .

Click here to see the complete history of Christopher Ogden’s form 4 insider trades.

Insider Ownership Summary of Christopher Ogden

Ticker Comapny Transaction Date Type of Owner
CTMX CytomX Therapeutics Inc 2024-03-19 SVP & Finance and Accounting

Christopher Ogden Latest Holdings Summary

Christopher Ogden currently owns a total of 1 stock. Christopher Ogden owns 85,686 shares of CytomX Therapeutics Inc (CTMX) as of March 19, 2024, with a value of $136,241.

Latest Holdings of Christopher Ogden

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CTMX CytomX Therapeutics Inc 2024-03-19 85,686 1.59 136,241

Holding Weightings of Christopher Ogden


Christopher Ogden Form 4 Trading Tracker

According to the SEC Form 4 filings, Christopher Ogden has made a total of 3 transactions in CytomX Therapeutics Inc (CTMX) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in CytomX Therapeutics Inc is the sale of 2,971 shares on March 19, 2024, which brought Christopher Ogden around $6,209.

Insider Trading History of Christopher Ogden

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Christopher Ogden Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Christopher Ogden Ownership Network

Ownership Network List of Christopher Ogden

No Data

Ownership Network Relation of Christopher Ogden


Christopher Ogden Owned Company Details

What does CytomX Therapeutics Inc do?

Who are the key executives at CytomX Therapeutics Inc?

Christopher Ogden is the SVP & Finance and Accounting of CytomX Therapeutics Inc. Other key executives at CytomX Therapeutics Inc include SVP & Chief Scientific Officer Marcia Belvin , Chief Financial Officer Jeffrey B Landau , and General Counsel Lloyd A Rowland .

CytomX Therapeutics Inc (CTMX) Insider Trades Summary

Over the past 18 months, Christopher Ogden made 3 insider transaction in CytomX Therapeutics Inc (CTMX) with a net sale of 5,477. Other recent insider transactions involving CytomX Therapeutics Inc (CTMX) include a net sale of 55,496 shares made by Sean A. Mccarthy , a net sale of 16,868 shares made by Lloyd A Rowland , and a net sale of 16,235 shares made by Jeffrey B Landau .

In summary, during the past 3 months, insiders sold 47,819 shares of CytomX Therapeutics Inc (CTMX) in total and bought 0 shares, with a net sale of 47,819 shares. During the past 18 months, 121,072 shares of CytomX Therapeutics Inc (CTMX) were sold and 5,000 shares were bought by its insiders, resulting in a net sale of 116,072 shares.

CytomX Therapeutics Inc (CTMX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

CytomX Therapeutics Inc Insider Transactions

No Available Data

Christopher Ogden Mailing Address

Above is the net worth, insider trading, and ownership report for Christopher Ogden. You might contact Christopher Ogden via mailing address: C/o Cytomx Therapeutics, Inc., 151 Oyster Point Blvd., Suite 400, South San Francisco Ca 94080.

Discussions on Christopher Ogden

No discussions yet.